Comparative Value and Economic Analysis

  • Early Stage Value Based Pricing  Analysis
  • Cost-Effectiveness Analysis
  • Budget-Impact (Actuarial) Analysis
  • Health Technology Assessment

The following is a list of modeling projects in oncology/diagnostics. Contact information from these organizations is available if further validation of Cedar’s expertise is needed:

Client Technology Modeling Service(s)
Quest Diagnostics, Inc. OVA1™: Ovarian cancer diagnostic Value based pricing model
Genomic Health, Inc. Oncotype Dx®: Diagnostics for:

  • Breast cancer
  • Colon cancer
  • Gastrointestinal (GI) cancer
  • Budget impact model (Colon)
  • Market demand model (Colon)
  • Value based pricing model
  • 2 each for breast, colon, GI cancer
Allegro Diagnostics, Inc. BronchoGen™: Lung cancer diagnostic Cost effectiveness analysis model
Genentech, Inc. Rituxan®: Treatment for Chronic Lymphocytic Leukemia (CLL)
  • Cost effectiveness analysis models for two indications
  • Budget impact model combining two indications
Johnson & Johnson, Inc. Velcade™: Treatment for Multiple Myeloma Cost effectiveness analysis model to support UK NICE submission


Cedar Associates has published extensively in the areas of oncology and diagnostics. Review the full list of publications authored by Cedar staff.